A Phase 3, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Efficacy, Pharmacodynamics and Safety in Patients Undergoing Mandibular Dental Procedures

Raybould, Ted (PI)

Oral Health Science

Status	Finished
Effective start/end date	4/15/05 → 4/30/07

Funding

Nova Pharmaceuticals: $13,069.00

1 Finished

A Phase 3, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Efficacy, Pharmacodynamics and Safety in Patients Undergoing Mandibular Dental Procedures SCOPE
Novak, M. (PI)
4/15/05 → 4/30/07
Project: Research project